"Central Care Cancer Center provides professional expertise, the latest cancer fighting technology, and unparalleled support services across the states of Kansas and Missouri. Central Care Cancer Center provides medical oncology, chemotherapy, hematology and radiation therapy services."

During the past decade, Central Care Cancer Center - Bolivar conducted 174 clinical trials. In the 10-year time frame, 174 clinical trials started and 95 clinical trials were completed, i.e. on average, 54.6% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 71 clinical trials were completed. i.e. 95.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Care Cancer Center - Bolivar" #1 sponsor was "National Cancer Institute (NCI)" with 103 trials, followed by "SWOG Cancer Research Network" with 40 trials sponsored, "Alliance for Clinical Trials in Oncology" with 33 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 24 trials sponsored and "GOG Foundation" with 24 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Care Cancer Center - Bolivar" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Central Care Cancer Center - Bolivar" are "Invasive Breast Carcinoma" (11 trials), "Breast Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (9 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Central Care Cancer Center - Bolivar" in a lesser frequency.

Most popular intervention types in "Central Care Cancer Center - Bolivar" are "Drug" (191 trials), "Other" (141 trials), "Biological" (100 trials), "Procedure" (60 trials) and "Radiation" (27 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (70 trials), "Quality-of-Life Assessment" (49 trials), "Biospecimen Collection" (31 trials), "Computed Tomography" (29 trials) and "Questionnaire Administration" (29 trials). Other intervention names were less common.

The vast majority of trials in "Central Care Cancer Center - Bolivar" are 202 trials for "All" genders, 35 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Central Care Cancer Center - Bolivar". undefined are not yet recruiting, 71 are recruiting, 103 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Central Care Cancer Center - Bolivar, 6 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Central Care Cancer Center - Bolivar, 6 "Phase 1" clinical trials were conducted, 115 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".